Evidence map›Paper›PMID 28174738›Full record

ArticleCellular and molecular gastroenterology and hepatology2016

Microgeographic Proteomic Networks of the Human Colonic Mucosa and Their Association With Inflammatory Bowel Disease.

Xiaoxiao Li, James LeBlanc, David Elashoff, Ian McHardy, Maomeng Tong, Bennett Roth, Andrew Ippoliti, Gildardo Barron, Dermot McGovern, Keely McDonald and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cellular and molecular gastroenterology and hepatology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Transcriptome Sequencing Reveals Potential Roles ofFrontiers in cell and developmental biology · 2020
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Xiaoxiao LiDepartment of Molecular and Medical Pharmacology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California; Department of Pathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California; Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
James LeBlancDepartment of Pathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
David ElashoffDepartment of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Ian McHardyDepartment of Pathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Maomeng TongDepartment of Molecular and Medical Pharmacology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Bennett RothDepartment of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Andrew IppolitiInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Gildardo BarronInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Dermot McGovernInflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California.
Keely McDonaldDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Rodney NewberryDepartment of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri.
Thomas GraeberDepartment of Molecular and Medical Pharmacology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Steve HorvathDepartment of Human Genetics and Biostatistics, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Lee GoodglickDepartment of Pathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
Jonathan BraunDepartment of Molecular and Medical Pharmacology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California; Department of Pathology and Laboratory Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California.
University of California, Los Angeles · USCedars-Sinai Medical Center · USWashington University in St. Louis · US

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Using polygenic scores to enhance both variant discovery, and understanding of functional consequences of genetic variation in IBD.P01DK046763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI TARGAN, STEPHAN R. · 1992 to 2020
$31.1M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Utilizing the Phenomics of IBD to Enhance Gene DiscoveryU01DK062413 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI Dermot Patrick McGovern · 2002 to 2026
$12.2M
GASTROENTEROLOGYT32DK007180 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI JENSEN, DENNIS MICHAEL · 1986 to 2025
$10.0M
Lymphotoxin Beta Receptor in Intestinal InflammationR01DK064798 · NIDDK · WASHINGTON UNIVERSITY · PI NEWBERRY, RODNEY D · 2005 to 2013
$2.8M
Identifying Microorganisms involved in Human Health and Disease ProcessesR01AI078885 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI BORNEMAN, JAMES · 2008 to 2011
$1.4M
NCATS NIH HHS UL1 TR000124NCATS NIH HHS UL1 TR001881NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI078885NIDDK NIH HHS P01 DK046763NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK064798NIDDK NIH HHS T32 DK007180NIDDK NIH HHS U01 DK062413
6 · The paper itself

Abstract

BACKGROUND &

aimsInteractions between mucosal cell types, environmental stressors, and intestinal microbiota contribute to pathogenesis in inflammatory bowel disease (IBD). Here, we applied metaproteomics of the mucosal-luminal interface to study the disease-related biology of the human colonic mucosa.

methodsWe recruited a discovery cohort of 51 IBD and non-IBD subjects endoscopically sampled by mucosal lavage at 6 colonic regions, and a validation cohort of 38 no-IBD subjects. Metaproteome data sets were produced for each sample and analyzed for association with colonic site and disease state using a suite of bioinformatic approaches. Localization of select proteins was determined by immunoblot analysis and immunohistochemistry of human endoscopic biopsy samples.

resultsCo-occurrence analysis of the discovery cohort metaproteome showed that proteins at the mucosal surface clustered into modules with evidence of differential functional specialization (eg, iron regulation, microbial defense) and cellular origin (eg, epithelial or hemopoietic). These modules, validated in an independent cohort, were differentially associated spatially along the gastrointestinal tract, and 7 modules were associated selectively with non-IBD, ulcerative colitis, and/or Crohn's disease states. In addition, the detailed composition of certain modules was altered in disease vs healthy states. We confirmed the predicted spatial and disease-associated localization of 28 proteins representing 4 different disease-related modules by immunoblot and immunohistochemistry visualization, with evidence for their distribution as millimeter-scale microgeographic mosaic.

conclusionsThese findings suggest that the mucosal surface is a microgeographic mosaic of functional networks reflecting the local mucosal ecology, whose compositional differences in disease and healthy samples may provide a unique readout of physiologic and pathologic mucosal states.

Indexed as

ANOVA, analysis of varianceCD, Crohn’s diseaseEcologyHBD, human β-defensinHD5, human alpha defensin 5HNP, human neutrophil peptideHPLC, high-performance liquid chromatographyIBD, inflammatory bowel diseaseIHC, immunohistochemistryInflammatory Bowel DiseaseMALDI, matrix-assisted laser desorption/ionizationMetaproteomicsMFN, mucosal functional networkMLI, mucosal–luminal interfaceMS/MS, tandem mass spectrometryMucosalNetworksNLME, nonlinear mixed-effect modelPVCA, principal variance component analysisTOF, time of flightUC, ulcerative colitisWGCNA, weighted correlation network analysis

Identifiers

PMID28174738
PMCPMC5042708
OpenAlexW2400012444

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.